Rosacea and Scaly Dermatoses Flashcards

(71 cards)

1
Q

Questions for the patient

A

When considering derm conditions:

What do the lesions look like (size, shape, color)?
How have the lesions changed over time?
Does it itch?
Is it painful?
What do you think the problem may be?
Are you having other symptoms (SOB, swelling, fever, or N/V)?
Where did the problem first appear?
Where are you affected?
Did it and how did it spread?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Rosacea

A

Skin disease that affects the middle third of the face. Causes persistent redness over the areas of the face and nose.
Mainly involves the forehead, the chin, and the lower half of the nose.
No confirmatory laboratory test.
No cure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Rosacea – predisposing factors

A
  • Between 30 and 50 years old
  • Fair-skinned
  • Often have blonde hair and blue eyes.
  • Likely to have someone in their family with rosacea or severe acne.
  • Likely to have had lots of acne — or acne cysts and/or nodules.
  • Females more than males, but, males have higher severity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Rosacea Subtypes

A

Subtype 1: Facial Redness
Subtype 2: Bumps and Pimples
Subtype 3: Skin thickening
Subtype 4: Eye irritation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Rosacea Subtype 1

A

FACIAL REDNESS

erythematotelangiectatic rosacea
Flushing and persistent redness. Visible blood vessels may also appear.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Rosacea Subtype 2

A

BUMPS AND PIMPLES

papulopustular rosacea
Persistent facial redness with bumps or pimples. Often seen following or with subtype 1.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Rosacea Subtype 3

A

SKIN THICKENING

phymatous rosacea
Skin thickening and enlargement, usually around nose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Rosacea Subtype 3

A

EYE IRRITATION

ocular rosacea
Watery or bloodshot appearance, irritation, burning or stinging.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Rosacea: Clinical presentation

A

Erythematotelangiectatic (subtype 1)
Persistant erythema of central face
Easily irritated facial skin

Papulopustular (subtype 2)
Above + dome-shaped erythematous papules and some pustules

Phymatous (subtype 3)
Thickened skin with prominent pores +/- Above

Ocular rosacea (subtype 4)  Both eyes usually affected
Conjunctivitis
Blepharitis
Styes
Keratitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Rosacea triggers / exacerbating factors

A
  • Prolonged sun / UV light exposure
  • Stress / Anxiety
  • Humidity / extremes of weather / wind
  • Exercise
  • Alcoholic beverages
  • Smoking
  • Hot and spicy foods
  • Medications – (eg., vasodilators, calcium channel blockers, opiates)
  • Microorganisms
  • –Demodex folliculorum (mite)
  • –Staphylococcus epidermidis
  • –Heliobacter pylori
  • –Bacillus oleronius
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Rosacea Non-pharmacologic

A

Basic Skin Care:

  • Moisturizer
  • Photoprotection
  • -SPF 15 or greater
  • -Broad Spectrum: UVA and UVB coverage
  • Gentle soap-free skin cleanser
  • Avoid astringents, toners, waterproof cosmetics
  • Avoid potentially exacerbating factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Rosacea Pharmacologic Treatment (Topical)

A

Topical agents:

  • Metronidazole 0.75% or 1% cream or gel
  • Azelaic Acid 15% gel
  • Brimonidine 0.33% gel (reduces redness only)
  • Sodium Sulfacetamide 10% + Sulfur 5% - (papulopustular)

Benzoyl peroxide 5% + Clindamycin 1% - (papulopustular )
Topical Retinoids – use with or without oral antibiotics in refractory rosacea

  • FDA approved
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Topical Metronidazole

A
  • Anti-inflammatory agent
  • Antimicrobial agent
  • Inhibits growth of Demodex brevis (mites)
  • Decreases reactive oxygen species generation

Side effects: burning, stinging, dryness, itching

Dosing
0.75% = Applied twice daily (gel, cream, lotion)
1% = Applied once daily
(gel, cream)

Face should be clean before application
Cosmetics may be used 5 minutes after application

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Azelaic Acid

A

15% gel, 20% cream

Anti-inflammatory Antibacterial agent
For mild to moderate papulopustular rosacea

Use twice daily on affected areas

Side effects : burning, stinging, itching, dryness, scaling
Reassess if not improvement after 12 weeks

Face should be clean before application
Cosmetics may be used after application

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Brimonidine

A

Alpha-2 agonist

Reduces facial erythema
Causes vasoconstriction in the smooth muscles of blood vessels in the skin

See effects at 30 minutes after application; persists up to 7 hours

May see rebound facial erythema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Rpsacea Pharmacological Treatment (Systemic)

A

Oral Agents

  • Doxycycline - 40 mg daily – anti-inflammatory dose
    Only systemic therapy approved by FDA for rosacea for up to 12 months

Antibiotic / Anti-inflammatory agents
resistance concerns

Azithromycin 250 – 500 mg three times per week for 2 – 6 weeks
Doxycycline 50 – 100 mg/day for 6 – 12 weeks
Minocycline 50 – 100 mg twice daily for 6 – 12 weeks
Metronidazole 200 mg once or twice daily for 4 – 6 weeks

Beta-blockers – to decrease erythema (limited studies w/Carvedilol; concern for CV effects)

Isotretinoin - limited data; Poorly tolerated
!!Not in females of reproductive age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Ocular Rosacea - treatment

A

Warm water soaks

Twice daily cleaning of base of lashes with no tears baby shampoo or lid cleanser, remove any crusting

Artificial Tear replacement

Topical Metronidazole gel

Oral Doxycycline or alternative antibiotic

Refer severe cases to ophthalmologist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Case 1: 47 year old woman with facial redness and flushing over past year. Eyes itch and are red. Worried about “whiskey” nose.

What is the initial medication treatment for this condition?

What medication can be added to reduce eye symptoms?

For management of rosacea, what is true?

A

What is the initial medication treatment for this condition?Metronidazole gel BID

What medication can be added to reduce eye symptoms? Doxycycline 40mg daily

For management of rosacea, what is true? should wear sunscreen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Scaly Dermatoses

A

Dandruff
Seborrhea
Psoriasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Distinguishing Dandruff

A
Scalp
Generally stable (not exacerabated) but does increase in dry climate

Appears thin, white or grey flakes on scalp

no inflammation

no epidermal hyperplasia (skin increase)

epidermal kinetics 2x faster than normal

less than 5% incompletely keratinized skin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Distinguishing Seborrhea

A

Head and Trunk

Exacerbated by external factors; Parkinson’s disease

Appears as macules, patches and thin plaques of discrete yellow, oily scales on red skin

Inflammation is present

Has epidermal hyperplasia (skin thickening)

Epidermal kinetics 3x faster than normal

15-25% incompletely keratinized cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Distinguishing Psoriasis

A

Scalp, elbows, knees, trunk, lower extremities

Exacerbated by irritation, stress, climate, medications, infection, endocrine

Appears discretely symmetrical, red plaques with sharp borders, silvery white scale

Inflammation is present

Has epidermal hyperplasia (skin thickening)

Epidermal kinetics are 5-6x faster than normal

40-60% incompletely keratinized cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

OTCs for scaly dermatoses

A

FOR Dandruff, Seborrhea, and Psoriasis:

Coal Tar
Ketoconazole (shampoo) Pyrithione Zinc (rinse off)
Pyrithione Zinc (residual)
Salicylic Acid
Selenium Sulfide

FOR dandruff and seborrhea
(NOT psoriasis)
Sulfur

For seborrhea and psoriasis
(NOT dandruff)
hydrocortisone 1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Dandruff

A

Chronic, non-inflammatory hyperproliferative epidermal scalp condition

Scales from irregular keratin cracking pattern

Pruritis common

Occurs in 1 – 3 % of population

Puberty onset

Peak occurrence in adulthood

No gender preference

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Dandruff Treatment Goals
Reduce epidermal turnover rate of scalp skin Minimize the cosmetic embarrassment of visible scaling Minimize itching
26
Dandruff General Treatment Approach
Mild presentation: -Non-medicated shampoo (Daily or every other day) Moderate to severe presentation : - OTC medicated shampoos (pyrithione zinc or selenium sulfide) - Leave on for 3 to 5 minutes - Rinse well with water - Use 2 – 3 times weekly for 2 to 3 weeks, then once weekly for control
27
Seborrheic Dermatitis occurance
Chronic inflammatory disorder occurring in areas of sebaceous gland activity Chronic condition with no specific cure Neither harmful nor contagious Affects 3 – 5% of adults, men more than women Ages 18 to 40 years
28
Seborrheic Dermatitis Features
Greasy or dry scaling of the scalp, sometimes a "cradle cap" Mildly scaling eczematous patches on the face at typical locations (eyebrows, nasolabial creases, "sideburn” area)often with itch and stinging Itch and inflammation of the ear canal Blepharitis (eyelid infection) Well-demarcated eczematous patches - --on mid-upper trunk - --at intertrigo areas (skin folds or juxtaposed surfaces of skin)
29
Seborrhea triggers / causes
- Malassezia (a yeast – like fungus) grows in the sebum along with bacteria - Hormones - Physical stress, fatigue, travel - Zinc deficiency - Obesity - Season Change (worse in cold weather) - HIV infection - Parkinsonism
30
Seborrheic Dermatitis Traetment goals
Reduce inflammation and epidermal turnover rate Minimize or eliminate visible erythema and scaling
31
Seborrheic Dermatitis General treatment approach / management strategies
- Loosen and remove scales and crusts - Inhibit yeast colonization (Malassezia) - Reduce erythema and itching - Avoid perfumes, aftershave, ointments, soaps - Control secondary infections
32
To Loosen and remove scales and crusts and decrease sebum (Seborrhea)
The scales can be softened with: - -Cream containing salicylic acid and sulphur - -Wetting and washing Seborrhoeic skin should be washed more often than twice daily
33
To Decrease Fungal Growth (Seborrhea)
Washing the scalp - -Ketoconazole shampoo [first line] or - -Selenium sulfide shampoo [second line] Shampoo scalp with medicated shampoo product daily for a week, then 2-3 times a week leave shampoo on hair, scalp and affected areas for 5 minutes; then rinse may repeat After 4 weeks (if see improvement) may reduce frequency of medicated shampoo to once weekly If worsens after 1 to 2 weeks on OTC meds/shampoo, refer to physician Topical treatment with Imidazole derivative creams Sometimes ultraviolet light therapy
34
To Reduce erythema and itching (seborrhea)
Corticosteroid lotion for the scalp (from mild to potent) Corticosteroid creams for other parts of the body (from mild to potent) Moisturizing emollients after washing Ketoconazole shampoo and corticosteroid lotion must often be combined in therapy-resistant cases.
35
Seborrheic treatment - infants
“Cradle cap” Remove scaling on scalp: - Massage scalp with baby oil - Use non-medicated shampoo - Soft bristle brush -For severe cases: Salicylic Acid 3 – 5 % in olive oil or water soluble base On face – wash with mild soap or cleanser, apply facial emollient – no steroids
36
A 35 yo man reports itching, redness, and scaling in his scalp, eyebrows and external auditory canal. He has tried several over-the-counter dandruff shampoos, with only temporary relief, and he is increasingly embarrassed by this problem. On exam, greasy scaling on the scalp and erythema with yellowish scales in the nasolabial creases. Primary problem? First medication product to suggest?
Primary problem? seborrhea First medication product to suggest? Ketoconazole shampoo
37
: A new mom comes to the pharmacy with an infant that looks to be a couple of weeks old. She asks about the scaly appearance of the infant’s scalp, if it is dangerous and what she should do. Primary problem? Treatment?
Primary problem? seborrhea, “cradle cap” Treatment? baby oil with gentle massage
38
Psoriasis- Patient Assessment
Measures of symptom and involvement: % Body surface area (BSA) involved Psoriasis Area and Severity Index (PASI) Physician’s Global Assessment (static PGA) Quality-of-life measures: Dermatology Life Quality Index (DLQI) Short Form (SF-36) Health Survey
39
Signs and Symptoms of plaque psoriasis
``` Lesions (plaques): Erythmatous Red-violet in color At least 0.5 cm in diameter Well demarcated Typically covered by silver, flaking scales ```
40
psoriasis skin involvement
Skin Involvement: Generalized over wide BSA Mild: less than or = to 5% BSA Moderate: PASI greater than or = to 8 (psoriasis area and severity index) Severe: PASI greater than or = to 10 OR DLQI is greater than or = to 10 or BSA is greater than or = to 10. (rule of 10s) (dermatology quality of life index)
41
psoriasis pruritis
Pruritis: More than 50% of patients have itching May be severe in some patients and require treatment to minimize excoriations from scratching
42
Other concerns with psoriasis
Other concerns: Lesions may be physically debilitating or socially isolating Potential comorbidities: PsA (psoriatic arthritis) depression, HTN,obesity, diabetes,Chrone's,anxiety, alcoholism
43
Psoriasis: Goals of treatment
- -Minimizing or eliminating the signs of psoriasis such as plaques and scales - -Alleviating pruritus and minimizing excoriations - -Reducing the frequency of flare-ups - -Ensuring appropriate treatment of associated conditions such as PsA (psoriatic arthritis), hypertension, dyslipidemia, diabetes, clinical depression, or itching - -Avoiding or minimizing adverse effects from topical or systemic treatments used - -Providing cost-effective therapy - -Providing guidance or counseling as needed (e.g., stress-reduction techniques) - -Maintaining or improving the patient's quality of life
44
All psoriasis patients – Healthy lifestyle recommendations
``` Reduce stress Regular exercise Weight management (aim for BMI 18.5-24.9) Moderation of alcohol consumption Cessation of smoking ```
45
Psoriasis Non-Pharmacologic treatments
For small areas or just a few patches Moisturizers / Emollients Oatmeal baths Sunscreen
46
Topical therapy options - Psoriasis
Corticosteriods Vitamin D3 analogue-Calcipotriene Retinoids-Tazarotene Anthralin Coal Tar Salicylic Acid: Calcineurin Inhibitors- Pimecrimolimus:
47
Psoriasis Systemic Agents
Oral retinoid-Acitretin Oral Tcell & cytokine suppressor-Methotrexate and Cyclosporin Oral Tcell Inhibitor-Alefacept (Amevive) Oral Monoclonal Tcell Inhibitor-Efalizzumab (Raptiva) Interleukin Inhibitor-Ustekinumab (Stelera) Biologic Agents-TNFa inhibitors
48
Corticosteroids for psoriasis
Corticosteriods: (topical) cream or lotion (day) ointment (night) 2-4 times daily
49
Vitamin D3 analogue for psoriasis
Vitamin D3 analogue-Calcipotriene: (topical) ointment- 1 or 2 times daily or cream or foam- twice daily
50
Retinoids for psoriasis (topical)
Retinoids- Tazarotene: (topical) Once daily at bedtime
51
Anthralin for psoriasis
Anthralin: (topical) Apply only to thick plaque lesions for 2 hrs or less (use zinc oxide around) Then wipe off
52
Coal Tar for Psoriasis
Coal Tar: (topical) Apply in evening Wash off in morning
53
Salicylic Acid for Psoriasis
Salicylic Acid: | Shampoo-for scalp lesions
54
Calcineurin Inhibitors for Psoriasis
Calcineurin Inhibitors- Pimecrimolimus: (topical) Apply to intertriginous areas (folds)
55
Retinoid for psoriasis (oral)
``` Oral retinoid Acitretin: Not immunosuppressive Max response 3-6 months Do not drink alcohol ``` Reproductive age women: should not be or plan to get pregnant within 3 years of discontinuing drug
56
Tcell and cytokine suppressor for psoriasis
Methotrexate (oral) For psoriasis and psoriatic arthritis Onset 3-6 weeks Admin w/ folic acid 1-5mg/day to decrease nausea, bone marrow suppression, hepatic toxicity Contraindicated:pregnancy, cirrhosis, blood dyscrasias (disorders) Increases risk of hepatotoxicity (DM, obese, alcoholism, >4g total cumulative dose)
57
Tcell and cytokine suppressor for psoriasis
Cyclosporin (DMARD) oral Not recommended for use over 4 months-nephrotoxic Dose on ACTUAL body weight Many drug interactions:major 3A4 substrate, 3A4 & 2C9 inhibitor Contraindicated:systemic malignancy, untreated HTN, infections Increases elderly risk of HTN
58
Tcell inhibitor for psoriasis
Alefacept (Amevive) Dose: 15mg IM every week for 12 weeks (follow w/ 12 weeks non-treatment) Contraindicated:HIV Monitor: CD4 base count, get CD4 counts q 2 wks during therapy (hold for count
59
Monoclonal Tcell inhibitor for psoriasis
Efalizumab (Raptiva) Dose: single 0.7 mg/kg SC (conditioning dose) then 1 mg/kg SC weekly (max single dose not to exceed 200 mg) Monitior: Platelet count monthly, may extend to every 3 mo w/ prolonged course NO live or attenuated vaccines during therapy
60
Interleukin inhibitor for psoriasis
Ustekinumab (Stelera) Dose 0-4 weeks: SC if under 100 kg; 90mh SC if over 100 kg then every 12 wks ``` Caution: -Avoid in active TB -Do not give concurrently with: ---live vaccines ---BCG ---pimecrolimus ---tacrolimus ---Echinacea (may decrease levels) ``` Monitor: PPD, CDC, signs of infection, antibody formation
61
TNFa Inhibitors for psoriasis
``` Biologic Agents: Adalimumab (Humira) Etanercept (Enbrel) Infliximab (Remicade) Golimumab (Simponi) Certolizumab (Cimzia) ``` Dose: see insert ``` TB testing (PPD) on all patients (repeat yearly) HepB screen is recommended ``` Monitor CBC & LFT Do not Use: live vaccine CHF patients Patients w/ or family that has demylenating disease or MS
62
mild-Moderate Psoriasis Treatment algorithm
Topical agents + moisturizers as needed (If controlled step down to lowest effective dose or potency) Inadequate: Topical+phototherapy+ moisturizer as needed (If controlled step down to lowest effective dose or potency) Inadequate: Topical+systemic+ moisturizer as needed (If controlled step down to lowest effective dose or potency)
63
Moderate-Sever Psoriasis Treatment Algorithm
Systemic +/- topical or photo+ moisturizer as needed (If controlled step down to lowest effective dose or potency) Inadequate: More potent systemic+/- topical + moisturizer as needed (If controlled step down to lowest effective dose or potency) OR 2 systemics in rotation (rarely done) +/- topical+moisturizer as needed (If controlled step down to lowest effective dose or potency) Inadequate: Biologic +/- other agents + moisturizer as needed (If controlled step down to lowest effective dose or potency) NOTE: may consider biologics earlier or even as first line BUT expensive
64
Mod-Severe psoriasis treatment (pediatric-no psoriatic arthritis)
Topical agent If UVB available: 1st line: UVB phototherapy (monotherapy) or UVB+Methotrexate ``` If No UVB: 1st line alpha order Adalimumab Cyclosporin Etanercept Infliximab Methotrexate PUVA ```
65
Peripheral Psoriatic Arthritis treatment
Nsaids or Local 1A steroids 1st DMARD 2nd DMARD 1st line TNFa inhibitor 2nd line TNFa inhibitor
66
Axial Psoriatic Arthritis Treatment
Nsaid or local 1A steroid 1st line TNFa inhibitor 2nd line TNFa inhibitor
67
Photochemotherapy
Last resort PUVA: Psoralen + UVA light MOA: Psoralen cross-links with DNA in presence of UVA light; effects immune response in skin and lymphocytes Reserved for patients with severe, refractory psoriasis Need skin biopsy of lesion to confirm diagnosis of psoriasis Efficacy: 90% with oral psoralens + UVA light Dosing 0.6-0.8mg/kg po every 2 hours before exposure to UVA light ``` Side effects: Serious burns Blistering Peeling Itching Nausea Potential increase in certain cancer rates ```
68
Pharmacoeconomics of Psoriasis Treatments
``` Costs of psoriasis therapy for moderate to severe disease: Cost of drug Cost of administration Cost of monitoring Cost of adverse effects Cost of failed treatment Cost of days off work Can be significant ($1000s), even with insurance ```
69
Psoriasis Patient Education
Fully inform patients / caregivers of benefits and risks of treatment options www. aad.org www. psoriasis.org
70
A 52 year old female, comes into the pharmacy to pick up her refills for enalapril and hydrochlorothiazide. She shows you two approximately 2 cm plaques on the ulnar surface of each elbow, they are covered with whitish silvery scales. DC states that these are new and appeared over the past week. Current meds: Enalapril / HCTZ NKDA DC also tells you that 15 years ago she was treated for psoriasis with tar and steroid creams for a couple of months, with good results She cannot get an appointment with a dermatologist for 8 weeks She asks your advice about what she can do in the meantime She has no joint symptoms
risk factors for psoriasis – winter treatment plan for this patient Moisturize appropriately, coal tar and steroid cream
71
Conclusion
Mild to moderate scaly dermatoses can often be effectively managed with topical non-prescription products Selection of products based on: Patient’s history Prior response to treatment Evaluation of risks vs. benefits of options Education of patients: Appropriate application of topical therapy Appropriate administration of oral therapy Follow-up should be a week after self-treatment begins